SREBF2 and cancer: While further experiments are required to reveal the full complexity of cancer-relevant pathways controlled by USP28 and SREBP2, the results provided by our study add an additional layer to the regulation of SREBP2 activity and open novel translational avenues for the treatment of squamous tumours.